SCHEMBL426357

SCHEMBL426357

COC(=O)c1ccccc1-c1ccc2c(c1)C(c1ccc(C)cc1)(c1ccc(C)cc1)c1ccccc1-2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A3 Q01959 4/20 0.54
▸ SLC6A4 P31645 3/20 0.54
▸ SLC6A2 P23975 1/20 0.54
▸ ROCK2 O75116 1/20 0.52
▸ CSF1R P07333 1/20 0.52
▸ KDR P35968 1/20 0.52
▸ FLT3 P36888 1/20 0.52
▸ GSK3A P49840 1/20 0.52
▸ GSK3B P49841 1/20 0.52
▸ CDK5 Q00535 1/20 0.52
▸ ROCK1 Q13464 1/20 0.52
▸ SLK Q9H2G2 1/20 0.52
▸ IRAK4 Q9NWZ3 1/20 0.52
▸ PDK2 Q15119 5/20 0.47
▸ CYP46A1 Q9Y6A2 1/20 0.44
▸ ESR1 P03372 1/20 0.42
▸ ESR2 Q92731 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16177483 0.82 PDK2 (0.55) PDK2ESR1ESR2KDM4ESMN1; SMN2
SCHEMBL29756627 0.82 PDK2 (0.55) PDK2ESR1ESR2KDM4ESMN1; SMN2
SCHEMBL29375118 0.82 PDK2 (0.55) PDK2ESR1ESR2KDM4ESMN1; SMN2
SCHEMBL29615782 0.82 PDK2 (0.55) PDK2ESR1ESR2KDM4ESMN1; SMN2
SCHEMBL16176940 0.82 PDK2 (0.55) PDK2ESR1ESR2KDM4ESMN1; SMN2
SCHEMBL29493741 0.82 PDK2 (0.55) PDK2ESR1ESR2KDM4ESMN1; SMN2
SCHEMBL249 0.81 SLC6A3 (0.73) SLC6A3SLC6A4SLC6A2ROCK2CSF1R
SCHEMBL29295035 0.80 SLC6A3 (0.64) SLC6A3SLC6A4SLC6A2ROCK2CSF1R
SCHEMBL29294796 0.78 SLC6A3 (0.61) SLC6A3SLC6A4SLC6A2ROCK2CSF1R
SCHEMBL29294780 0.77 SLC6A3 (0.57) SLC6A3SLC6A4SLC6A2ROCK2CSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9349960-B2 Compounds and polymers which contain substituted indenofluorene derivatives as structural unit, process for the preparation thereof, and the use thereof as electronic devices and mixtures and solutions MERCK PATENT GMBH (DE) 2016-05-24 — — US disclosed
US-9349960-B2 Compounds and polymers which contain substituted indenofluorene derivatives as structural unit, process for the preparation thereof, and the use thereof as electronic devices and mixtures and solutions MERCK PATENT GMBH (DE) 2016-05-24 — — US disclosed
US-20120061617-A1 POLYMERS WHICH CONTAIN SUBSTITUTED INDENOFLUORENE DERIVATIVES AS STRUCTURAL UNIT, PROCESS FOR THE PREPARATION THEREOF, AND THE USE THEREOF MERCK PATENT GMBH (DE) 2012-03-15 — — US disclosed
US-20120061617-A1 POLYMERS WHICH CONTAIN SUBSTITUTED INDENOFLUORENE DERIVATIVES AS STRUCTURAL UNIT, PROCESS FOR THE PREPARATION THEREOF, AND THE USE THEREOF MERCK PATENT GMBH (DE) 2012-03-15 — — US disclosed
WO-2010136110-A2 POLYMERS COMPRISING SUBSTITUTED INDENOFLUORENE DERIVATES AS STRUCTURAL UNITS, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF MERCK PATENT GMBH (DE) 2010-12-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120061617-A1 POLYMERS WHICH CONTAIN SUBSTITUTED INDENOFLUORENE DERIVATIVES AS STRUCTURAL UNIT, PROCESS FOR THE PREPARATION THEREOF, AND THE USE THEREOF PPID, PCID2, OCIAD1 SLC6A3 2056/4885SLC6A4 2001/4885SLC6A2 1717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback